How did you decide to participate in the Biomapas Academy?
When I used to walk past a pharmacy every day, I could never stop dreaming about being able to help people and develop innovative pharmaceuticals. So while studying biomedical sciences, I became interested in the drug development paths, which led me to medicinal chemistry. And one day at the university, I saw a poster about the Biomapas Academy, which could help me understand what, how, where, and when happens to pharmaceutical products during the whole journey to reach us, so I signed up for it without hesitation. Even though I am usually not a lucky person, I was selected to be one of the participants, which surprised me!
How was your experience regarding the Academy?
During the few months, I deepened my existing knowledge of drug development stages and expanded it to learn more about drug regulation and pharmacovigilance. After graduating from the Academy, I got the opportunity to try out regulatory affairs as part of Biomapas – I completed a summer internship in the Regulatory Affairs department.
How do you feel after graduating from the Academy?
I will never forget this practice in my life, not only because it fulfilled what I was looking for, but it let me realize that I want to return to this company after my graduation and put my accumulated knowledge to use. Thanks again to all Biomapas staff for their insights and advice, and I hope to see you soon.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Global Literature Review: Ensuring Safety through Robust Processes
Learn how our end-to-end GLR process enhances patient safety and supports regulatory compliance worldwide.
Site Startup Services in Clinical Trials: Leveraging Local Expertise
Learn how integrating site startup services within a flexible FSP model accelerates activation in CIS and CEE, reduces contract cycles, and improves predictability from first submission to first patient in.
Pharmacovigilance outsourcing for boosting compliance and safety for biotech companies
Explore why pharmacovigilance outsourcing is essential for biotech companies in 2025 to ensure compliance and patient safety.
Local Affiliate Services That Deliver the Best Results
Find out how local affiliate services can reduce compliance risks and support effective regulatory strategies in the pharma industry.
The Perfect Partnership: How Mid-Sized CROs and Site Networks Deliver Clinical Trial Success
In this webinar, learn how the right size of CRO and the right type of site network partnership can deliver clinical trial success.
Breaking the Silos Across Medical Information & Pharmacovigilance – Leveraging Technology for Operational Efficiency
This whitepaper shows how a PV/MI Single Source of Truth boosts data management, compliance, and efficiency for complex therapies.
Harmonizing Product Information Across Baltic Markets
Navigating multilingual product information across several markets can be complex – but it doesn’t have to be. In this case study, we share how one of our partner companies successfully harmonized their SmPC, PIL, and labelling across the Baltic region, working with...
Dossier Transformation for Market Expansion
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...
Whitepaper: Computerised System Validation & Pharmacovigilance
This whitepaper explores how optimised computer system validation (CSV) strategies strengthen risk management, ensure data integrity in pharmacovigilance systems, and support compliance through a real-world cloud-based safety database case study.
Unlock Trial Success with the FSP Hybrid Model
Learn how the FSP hybrid model combines the best of FSO and FSP in clinical trials, enhancing operational control and flexibility.
